Qingdao Baheal Medical Inc
SZSE:301015
Qingdao Baheal Medical Inc
Cash from Investing Activities
Qingdao Baheal Medical Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Q
|
Qingdao Baheal Medical Inc
SZSE:301015
|
Cash from Investing Activities
-¥159.5m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Investing Activities
-¥944.5m
|
CAGR 3-Years
25%
|
CAGR 5-Years
31%
|
CAGR 10-Years
14%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Investing Activities
¥1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Investing Activities
-¥1.5B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-11%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Investing Activities
-¥115.8m
|
CAGR 3-Years
-115%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Investing Activities
-¥2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-20%
|
See Also
What is Qingdao Baheal Medical Inc's Cash from Investing Activities?
Cash from Investing Activities
-159.5m
CNY
Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Cash from Investing Activities amounts to -159.5m CNY.
What is Qingdao Baheal Medical Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-19%
Over the last year, the Cash from Investing Activities growth was -36%. The average annual Cash from Investing Activities growth rates for Qingdao Baheal Medical Inc have been -55% over the past three years , -19% over the past five years .